Table 1.
Breast Cancer Subtype | Receptor Status | Breast Cancer Cases | Stage I 5-year survival | Metastatic Median Survival |
---|---|---|---|---|
Estrogen Receptor and Progesterone Receptor Positive | ER+/PR+ | 70% | ≥ 99 | 4–5 y |
Human Epidermal Growth Factor 2 Receptor Positive | HER2+ | 15–20% | ≥ 94 | 5 y |
Triple Receptor Negative Breast Cancer | TNBC | 15% | ≥ 85 | 10–13 months |